Syngene International Ltd (SYNG IN): Well-Positioned to Capitalize On Strong Industry Tailwind
Through capacity and capability addition in biologics manufacturing and expansion of commercial API manufacturing, Syngene has expanded collaborations with existing clients as well as won new clients.
Equity Bottom-Up
327 Views, 08 Feb 2023 19:47
SUMMARY(Sign Up to Access)
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network